Testing effectiveness (Phase 2)Ended earlyNCT04566445
What this trial is testing
HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
Who this might be right for
Dry Age-related Macular Degeneration
Gyroscope Therapeutics Limited 255